The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Han Queena since 2015.
The trader's CIK number is 1638986.
At the time of the last reporting, Han Queena was the VP Finance & HR of Xbiotech Inc.. (stock ticker symbol XBIT).
Also see all insider trading activities at Xbiotech Inc..
Insider Buying | Insider Sales | Option Exercises | |||||
---|---|---|---|---|---|---|---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
2020 | XBIT | 0 | $0 | 53,141 | $1,043,973 | 110,833 | $625,933 |
2018 | XBIT | 0 | $0 | 80,000 | $378,072 | 80,000 | $199,999 |
2016 | XBIT | 0 | $0 | 20,000 | $300,000 | 20,000 | $14,812 |
2015 | XBIT | 0 | $0 | 30,000 | $314,309 | 30,000 | $21,600 |
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2020-09-01 | XBIT | Option Ex | 57,692 | 4.20 | 242,306 |
2020-08-24 | XBIT | Option Ex | 51,841 | 7.21 | 373,877 |
2020-08-24 | XBIT | Sale | 51,841 | 19.65 | 1,018,883 |
2020-08-17 | XBIT | Option Ex | 1,300 | 7.50 | 9,750 |
2020-08-17 | XBIT | Sale | 1,300 | 19.30 | 25,090 |
2018-03-22 | XBIT | Option Ex | 62,200 | 2.50 | 155,500 |
2018-03-21 | XBIT | Option Ex | 9,599 | 2.50 | 23,997 |
2018-03-23 | XBIT | Sale | 8,201 | 4.75 | 38,954 |
2018-03-22 | XBIT | Sale | 62,200 | 4.76 | 296,134 |
2018-03-21 | XBIT | Sale | 9,599 | 4.48 | 42,984 |
2018-03-23 | XBIT | Option Ex | 8,201 | 2.50 | 20,502 |
2016-11-15 | XBIT | Option Ex | 19,573 | .74 | 14,484 |
2016-11-15 | XBIT | Sale | 19,573 | 15.00 | 293,595 |
2016-09-08 | XBIT | Sale | 427 | 15.00 | 6,405 |
2016-09-08 | XBIT | Option Ex | 427 | .77 | 328 |
2015-12-21 | XBIT | Option Ex | 10,000 | .72 | 7,200 |
2015-12-18 | XBIT | Sale | 10,000 | 10.78 | 107,820 |
2015-12-18 | XBIT | Option Ex | 10,000 | .72 | 7,200 |
2015-12-22 | XBIT | Sale | 10,000 | 10.27 | 102,739 |
2015-12-21 | XBIT | Sale | 10,000 | 10.38 | 103,750 |
2015-12-22 | XBIT | Option Ex | 10,000 | .72 | 7,200 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Han Queena (VP Finance & HR of Xbiotech Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.